Zolaire

1 statements across 1 episodes · 0 bullish · 0 bearish · 1 people on the record · first statement Feb 28, 2019 by Koki Hirasaki · across every show →

Everything said about Zolaire, oldest first

Feb 28, 2019 neutral
Assertion Partly supported
Hirasaki: Major biopharma companies faced critical patent cliffs in 2018
“Roche lost exclusivity on Zolaire and Rituxin. Pfizer lost exclusivity on Lyrica. And GSK lost exclusivity on Advair.”
Koki Hirasaki Feb 28, 2019 ▶ 1:30 What’s with All the Bio M&A in 2019?: A Quick Take
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,000 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.